934286-16-5

Basic information

• Product Name: methyl 4-{2-[5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy}benzoate
• Synonyms: methyl 4-{2-[5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy}benzoate
• CAS NO: 934286-16-5
• Molecular Weight: 727.708
• Mol File: 934286-16-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: methyl 4-{2-[5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy}benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-{2-[5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy}benzoate(934286-16-5)
• EPA Substance Registry System: methyl 4-{2-[5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy}benzoate(934286-16-5)

Safety Data

• Hazardous Substances Data: 934286-16-5(Hazardous Substances Data)

Upstream product

• 479422-26-9 methyl 4-{2-[5-chloro-1-(diphenylmethyl)-2-formyl-1H-indol-3-yl]ethoxy}benzoate 
• 683813-75-4 C₃₂H₂₆Br₂ClNO₃ 
• 934284-96-5 methyl 4-(2-{5-chloro-1-(diphenylmethyl)-2-[(E)-2-nitrovinyl]-1H-indol-3-yl}ethoxy)benzoate 
• 479422-24-7 methyl 4-[2-[5-chloro-(1-diphenylmethyl)-2-methyl-1H-indol-3-yl]ethoxy]benzoate 
• 540522-69-8 methyl 4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate amine 
• 77421-13-7 (2-chlorobenzyl)sulfonyl chloride 

Relevant articles and documents

Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis

This invention provides methods for the use of substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof. The invention provides methods for the use of the compounds in the treating or preventing thrombosis in a mammal, or preventing progression of symptoms of thrombosis.

Discovery of ecopladib, an indole inhibitor of cytosolic phospholipase A2α

The synthesis and structure-activity relationship of a series of indole inhibitors of cytosolic phospholipase A2α (cPLA 2α, type IVA phospholipase) are described. Inhibitors of cPLA2α are predicted to be efficacious in treating asthma as well as the signs and symptoms of osteoarthritis, rheumatoid arthritis, and pain. The introduction of a benzyl sulfonamide substituent at C2 was found to impart improved potency of these inhibitors, and the SAR of these sulfonamide analogues is disclosed. Compound 123 (Ecopladib) is a submicromolar inhibitor of cPLA2α in the GLU micelle and rat whole blood assays. Compound 123 displayed oral efficacy in the rat carrageenan air pouch and rat carrageenan-induced paw edema models.